Dr. Alise Pharma Private Limited - Company Profile

It is a chemicals private limited company based in Hyderebad, Telangana, India, established in 2009.
2009 Hyderebad, Telangana, India Struck Off
Last Updated:
Access Report
About Dr. Alise Pharma Private Limited

Dr. Alise Pharma Private Limited, a struck off private limited company, was established on 09 February 2009 in Hyderebad, Telangana, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24233TG2009PTC062749. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Ravi Kattaguri (Managing Director), Venkata Kamalakar Marripalepu (Director), Chandra Sekhar Gajam (Director). It is based at S2-C-72, Sachivalaya Nagar Vanasthalipuram, Hyderebad, Telangana, 500070.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24233TG2009PTC062749

  • Registration Number

    062749

  • Incorporation Date

    09 February 2009

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 17 Year, 5 Days
Company report

Dr. Alise Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Dr. Alise Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Dr. Alise Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Ravi Kattaguri Managing Director 09 Feb 2009 Current
Venkata Kamalakar Marripalepu Director 09 Feb 2009 Current
Chandra Sekhar Gajam Director 09 Feb 2009 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Dr. Alise Pharma.

Enhance accessibility to Dr. Alise Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Dr. Alise Pharma revenue growth over time
Dr. Alise Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Dr. Alise Pharma?

Unlock access to Dr. Alise Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Dr. Alise Pharma?

Unlock and access historical data on people associated with Dr. Alise Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Dr. Alise Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr. Alise Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Dr. Alise Pharma
Recent Activity within the Organization
  • Director Appointment

    The activity Ravi Kattaguri was appointed as a Managing Director was appointed as a Managing Director on 09 Feb 2009 & has been associated with this company since 17 years 5 days . was completed.

  • Director Appointment

    The activity Venkata Kamalakar Marripalepu was appointed as a Director was appointed as a Director on 09 Feb 2009 & has been associated with this company since 17 years 5 days . was completed.

  • Director Appointment

    Progress on Chandra Sekhar Gajam was appointed as a Director was appointed as a Director on 09 Feb 2009 & has been associated with this company since 17 years 5 days . was documented.

  • Company Incorporation

    Progress on Dr. Alise Pharma Private Limited was registered on 09 Feb 2009 with Roc Hyderabad & aged 17 years 5 days as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Dr. Alise Pharma Private Limited?

The CIN of Dr. Alise Pharma Private Limited is U24233TG2009PTC062749.

Where is Dr. Alise Pharma Private Limited headquartered?

Dr. Alise Pharma Private Limited is headquartered at S2-C-72, Sachivalaya Nagar Vanasthalipuram, Hyderebad, Telangana, 500070.

When was Dr. Alise Pharma Private Limited incorporated?

Dr. Alise Pharma Private Limited was incorporated on 09 February 2009.

Who are the current directors of Dr. Alise Pharma Private Limited?

The current directors of Dr. Alise Pharma Private Limited are

What is the primary industry of Dr. Alise Pharma Private Limited?

The primary industry of Dr. Alise Pharma Private Limited is Chemicals.

Is Dr. Alise Pharma Private Limited a listed company?

Dr. Alise Pharma Private Limited is unlisted.

What is the capital structure of Dr. Alise Pharma Private Limited?

The authorized capital of Dr. Alise Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available